Ocugen Stock Rises On Better-Than-Feared Q1 Loss: Retail Turns Bullish CEO Shankar Musunuri said that the company is “on track” to meet its goal of submitting applications to the FDA requesting approval for the distribution of three of its products in the next three years.
Ocugen Stock Lifts Retail Investor Confidence As Q4 Revenue Crushes Estimates Watchers on Stocktwits expressed optimism about the company’s pipeline and its aim to secure three BLAs over the next three years.
Ocugen (OCGN) Q4 2024 Earnings Call Transcript OCGN earnings call for the period ending December 31, 2024.
Ocugen (OCGN) Q3 2024 Earnings Call Transcript OCGN earnings call for the period ending September 30, 2024.
Ocugen (OCGN) Q2 2024 Earnings Call Transcript OCGN earnings call for the period ending June 30, 2024.
Why Ocugen (OCGN) Stock Is Falling Ocugen shares are trading lower by 11% Thursday morning. The company announced the pricing of its public offering.
1 Biotech Stock to Buy Hand Over Fist and 1 to Avoid These two stocks could have vastly different long-term performances.
3 Penny Stocks That Could Turn $10K Into $100K in 3 Years Discover three high-potential penny stocks that could derive 10X returns in biotechnology, silver and oil and gas storage and transportation.
7 A-Rated Penny Stocks to Beat June Gloom Some penny stocks can be diamonds in the rough. These A-rated penny stocks are all solid picks for a portfolio this month.
3 Penny Stocks Set to Make New Millionaires in 2024 Explore the best penny stocks to buy and their progressive fundamentals in biotechnology, healthcare, and electrical components.
7 A-Rated Biotech Stocks Worth Betting on in June A-rated biotech stocks are highly coveted because they are at the forefront – or in the midst of -- groundbreaking innovation.
